Niklas F Müller Matthias Schampera Gerhard Jahn Nisar P Malek Christoph P Berg Klaus Hamprecht
10.1186/s12879-016-1343-3
BMC Infect Dis
2016 Jan 19;16:19.
CC BY
https://pubmed.ncbi.nlm.nih.gov/26787617/
Antiviral Agents / administration & dosage Cytomegalovirus / physiology Cytomegalovirus Infections / complications Disseminated Intravascular Coagulation / drug therapy Ganciclovir / analogs & derivatives
Antiviral Agents / administration & dosage Cytomegalovirus / physiology Cytomegalovirus Infections / complications Disseminated Intravascular Coagulation / drug therapy Ganciclovir / analogs & derivatives Case Reports Cytomegalovirus / drug effects Cytomegalovirus Infections / immunology Cytomegalovirus Infections / microbiology Disseminated Intravascular Coagulation / etiology Ganciclovir / administration & dosage Humans Immunocompromised Host Male Middle Aged Valganciclovir Antiviral Agents Valganciclovir Ganciclovir
PMC4719720
26787617
Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
2016